The DOI matches its Crossref record; 92 of the 92 references it cites were found in a registry or an index.
Molecular pathogenesis of mantle cell lymphoma
Open accessAbstract
Mantle cell lymphoma is a B cell malignancy in which constitutive dysregulation of cyclin D1 and the cell cycle, disruption of DNA damage response pathways, and activation of cell survival mechanisms contribute to oncogenesis.A small number of tumors lack cyclin D1 overexpression, suggesting that its dysregulation is always not required for tumor initiation.Some cases have hypermutated IGHV and stable karyotypes, a predominant nonnodal disease, and an indolent clinical evolution, which suggests that they may correspond to distinct subtypes of the disease.In this review, we discuss the molecular pathways that contribute to pathogenesis, and how improved understanding of these molecular mechanisms offers new perspectives for the treatment of patients.the European Mantle Cell Lymphoma Network and the Mantle Cell Lymphoma Consortium of the Lymphoma Research Foundation for their continuous collaboration on these projects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia
Puente, X. S., Pinyol, M., Quesada, V., Conde, L., Ordóñez, G. R., Villamor, N., Escaramis, G., Jares, P., Beà, S., González-Díaz, M., et al. (2011) · Nature · doi:10.1038/nature10113 · Cited by 1,514
Self-citationMinireview: Cyclin D1: Normal and Abnormal Functions
Fu, M., Wang, C., Li, Z., Sakamaki, T., & Pestell, R. G. (2004) · Endocrinology · doi:10.1210/en.2004-0959 · Cited by 966
Rosenwald, A., Wright, G., Wiestner, A., Chan, W. C., Connors, J. M., Campo, E., Gascoyne, R. D., Grogan, T. M., Muller-Hermelink, H. K., Smeland, E. B., et al. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00028-x · Cited by 914
Self-citationWilson, W. H., O'Connor, O. A., Czuczman, M. S., LaCasce, A. S., Gerecitano, J. F., Leonard, J. P., Tulpule, A., Dunleavy, K., Xiong, H., Chiu, Y.-L., et al. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70261-8 · Cited by 876 · cited 1×
“use of proapoptotic molecules that mimic the activity of BH3-only proteins (105) has shown promising Results in preclinical models (106–108) but no responses or only modest activity in clinical studies (82, 109).”
Friedberg, J. W., Sharman, J., Sweetenham, J., Johnston, P. B., Vose, J. M., LaCasce, A., Schaefer-Cutillo, J., De Vos, S., Sinha, R., Leonard, J. P., et al. (2010) · Blood · doi:10.1182/blood-2009-08-236471 · Cited by 747
Hess, G., Herbrecht, R., Romaguera, J., Verhoef, G., Crump, M., Gisselbrecht, C., Laurell, A., Offner, F., Strahs, A., Berkenblit, A., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.20.7977 · Cited by 641
Analysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activation
Fabbri, G., Rasi, S., Rossi, D., Trifonov, V., Khiabanian, H., Ma, J., Grunn, A., Fangazio, M., Capello, D., Monti, S., et al. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20110921 · Cited by 610
Identification and characterization of circulating human transitional B cells
Sims, G. P., Ettinger, R., Shirota, Y., Yarboro, C. H., Illei, G. G., & Lipsky, P. E. (2005) · Blood · doi:10.1182/blood-2004-11-4284 · Cited by 604
Phase II Trial of Single-Agent Temsirolimus (CCI-779) for Relapsed Mantle Cell Lymphoma
Witzig, T. E., Geyer, S. M., Ghobrial, I., Inwards, D. J., Fonseca, R., Kurtin, P., Ansell, S. M., Luyun, R., Flynn, P. J., Morton, R. F., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.13.466 · Cited by 514
Pérez-Galán, P., Roué, G., Villamor, N., Montserrat, E., Campo, E., & Colomer, D. (2006) · Blood · doi:10.1182/blood-2005-05-2091 · Cited by 467
Self-citationJares, P., Colomer, D., & Campo, E. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2230 · Cited by 466
Self-citationGenomic and Gene Expression Profiling Defines Indolent Forms of Mantle Cell Lymphoma
Fernàndez, V., Salamero, O., Espinet, B., Solé, F., Royo, C., Navarro, A., Camacho, F., Beà, S., Hartmann, E., Amador, V., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3419 · Cited by 463
Self-citationmTOR signaling and drug development in cancer
Dancey, J. (2010) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2010.21 · Cited by 417
Mozos, A., Royo, C., Hartmann, E., De Jong, D., Baro, C., Valera, A., Fu, K., Weisenburger, D. D., Delabie, J., Chuang, S.-S., et al. (2009) · Haematologica · doi:10.3324/haematol.2009.010264 · Cited by 398
Self-citationBcl-2 inhibitors: small molecules with a big impact on cancer therapy
Vogler, M., Dinsdale, D., Dyer, M. J. S., & Cohen, G. M. (2009) · Cell Death & Differentiation · doi:10.1038/cdd.2008.137 · Cited by 357
Outcome of Deferred Initial Therapy in Mantle-Cell Lymphoma
Martin, P., Chadburn, A., Christos, P., Weil, K., Furman, R. R., Ruan, J., Elstrom, R., Niesvizky, R., Ely, S., DiLiberto, M., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.19.6121 · Cited by 339
Whole transcriptome sequencing reveals recurrent NOTCH1 mutations in mantle cell lymphoma
Kridel, R., Meissner, B., Rogic, S., Boyle, M., Telenius, A., Woolcock, B., Gunawardana, J., Jenkins, C., Cochrane, C., Ben-Neriah, S., et al. (2012) · Blood · doi:10.1182/blood-2011-11-391474 · Cited by 338
A function for cyclin D1 in DNA repair uncovered by protein interactome analyses in human cancers
Jirawatnotai, S., Hu, Y., Michowski, W., Elias, J. E., Becks, L., Bienvenu, F., Zagozdzon, A., Goswami, T., Wang, Y. E., Clark, A. B., et al. (2011) · Nature · doi:10.1038/nature10155 · Cited by 333
Bortezomib for the Treatment of Mantle Cell Lymphoma
Kane, R. C., Dagher, R., Farrell, A., Ko, C.-W., Sridhara, R., Justice, R., & Pazdur, R. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0871 · Cited by 332
Orchard, J. A., Garand, R., Davis, Z. A., Babbage, G., Sahota, S. S., Matutes, E., Catovsky, D., Thomas, P., Avet‐Loiseau, H., & Oscier, D. G. (2003) · Blood · doi:10.1182/blood-2002-06-1864 · Cited by 320
Pham, L. V., Tamayo, A. T., Yoshimura, L. C., Lo, P., & Ford, R. J. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.1.88 · Cited by 320
Tiemann, M., Schrader, C., Klapper, W., Dreyling, M. H., Campo, E., Norton, A., Berger, F., Kluin, P., Ott, G., Pileri, S., et al. (2005) · British Journal of Haematology · doi:10.1111/j.1365-2141.2005.05716.x · Cited by 315
Self-citationTNFAIP3/A20 functions as a novel tumor suppressor gene in several subtypes of non-Hodgkin lymphomas
Honma, K., Tsuzuki, S., Nakagawa, M., Tagawa, H., Nakamura, S., Morishima, Y., & Seto, M. (2009) · Blood · doi:10.1182/blood-2008-12-194852 · Cited by 305
Weston, V. J., Oldreive, C. E., Skowronska, A., Oscier, D. G., Pratt, G., Dyer, M. J. S., Smith, G., Powell, J. E., Rudzki, Z., Kearns, P., et al. (2010) · Blood · doi:10.1182/blood-2010-01-265769 · Cited by 300
Selective CDK4/6 inhibition with tumor responses by PD0332991 in patients with mantle cell lymphoma
Leonard, J. P., LaCasce, A. S., Smith, M. R., Noy, A., Chirieac, L. R., Rodig, S. J., Yu, J. Q., Vallabhajosula, S., Schoder, H., English, P., et al. (2012) · Blood · doi:10.1182/blood-2011-10-388298 · Cited by 299 · cited 1×
“The pan-CDK inhibitor flavopiridol has shown minimal antitumoral activity (99), but in contrast PD-0332991, an inhibitor of CDK4 and CDK6, has shown biological effects (reduced retinoblastoma phosphorylation and Ki67 index) and some clinical benefit in a subset of patients (100).”
Beà, S., Ribas, M., Hernández‐Rivas, J. M., Bosch, F., Pinyol, M., Hernández, L., Garcı́a, J. L., Flores, T., González, M., López‐Guillermo, A., et al. (1999) · PubMed · doi:10.1182/blood.v93.12.4365 · Cited by 284
Self-citationConstitutive activation of Akt contributes to the pathogenesis and survival of mantle cell lymphoma
Rudelius, M., Pittaluga, S., Nishizuka, S., Pham, T. H.-T., Fend, F., Jaffe, E. S., Quintanilla-Martinez, L., & Raffeld, M. (2006) · Blood · doi:10.1182/blood-2006-04-015586 · Cited by 277
Kouroukis, C. T., Belch, A., Crump, M., Eisenhauer, E., Gascoyne, R. D., Meyer, R., Lohmann, R., Lopez, P., Powers, J., Turner, R., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.09.057 · Cited by 277
Transcriptional role of cyclin D1 in development revealed by a genetic-proteomic screen
Bienvenu, F., Jirawatnotai, S., Elias, J. E., Meyer, C. A., Mizeracka, K., Marson, A., Frampton, G. M., Cole, M. F., Odom, D. T., Odajima, J., et al. (2010) · Nature · doi:10.1038/nature08684 · Cited by 276
Hernandez, L., Fest, T., Cazorla, M., Teruya-Feldstein, J., Bosch, F., Peinado, M., Piris, M., Montserrat, E., Cardesa, A., Jaffe, E., et al. (1996) · Blood · doi:10.1182/blood.v87.8.3351.bloodjournal8783351 · Cited by 275
Self-citationNavarro, A., Clot, G., Royo, C., Jares, P., Hadzidimitriou, A., Agathangelidis, A., Bikos, V., Darzentas, N., Papadaki, T., Salaverria, I., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-1615 · Cited by 256
Self-citationWiestner, A., Tehrani, M., Chiorazzi, M., Wright, G., Gibellini, F., Nakayama, K., Liu, H., Rosenwald, A., Muller-Hermelink, H. K., Ott, G., et al. (2007) · Blood · doi:10.1182/blood-2006-08-039859 · Cited by 252
Self-citationAggarwal, P., Vaites, L. P., Kim, J. K., Mellert, H., Gurung, B., Nakagawa, H., Herlyn, M., Hua, X., Rustgi, A. K., McMahon, S. B., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.08.012 · Cited by 242
Targeting Notch signaling pathway to overcome drug resistance for cancer therapy
Wang, Z., Li, Y., Ahmad, A., Azmi, A. S., Banerjee, S., Kong, D., & Sarkar, F. H. (2010) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2010.06.001 · Cited by 233
Pinyol, M., Hernandez, L., Cazorla, M., Balbı́n, M., Jares, P., Fernandez, P. L., Montserrat, E., Cardesa, A., Lopez-Otı́n, C., & Campo, E. (1997) · Blood · doi:10.1182/blood.v89.1.272 · Cited by 226
Self-citationRizzieri, D. A., Feldman, E., DiPersio, J. F., Gabrail, N., Stock, W., Strair, R., Rivera, V. M., Albitar, M., Bedrosian, C. L., & Giles, F. J. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1372 · Cited by 222
Kirschbaum, M., Frankel, P., Popplewell, L., Zain, J., Delioukina, M., Pullarkat, V., Matsuoka, D., Pulone, B., Rotter, A. J., Espinoza-Delgado, I., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.32.1398 · Cited by 213
Ek, S., Dictor, M., Jerkeman, M., Jirström, K., & Borrebaeck, C. A. K. (2008) · Blood · doi:10.1182/blood-2007-06-093401 · Cited by 204
Ansell, S. M., Inwards, D. J., Rowland, K. M., Flynn, P. J., Morton, R. F., Moore, D. F., Kaufmann, S. H., Ghobrial, I., Kurtin, P. J., Maurer, M., et al. (2008) · Cancer · doi:10.1002/cncr.23580 · Cited by 203
Kurtova, A. V., Tamayo, A. T., Ford, R. J., & Burger, J. A. (2009) · Blood · doi:10.1182/blood-2008-10-185827 · Cited by 199
Rinaldi, A., Kwee, I., Taborelli, M., Largo, C., Uccella, S., Martin, V., Poretti, G., Gaidano, G., Calabrese, G., Martinelli, G., et al. (2006) · British Journal of Haematology · doi:10.1111/j.1365-2141.2005.05883.x · Cited by 195
ATM Deficiency Sensitizes Mantle Cell Lymphoma Cells to Poly(ADP-Ribose) Polymerase-1 Inhibitors
Williamson, C. T., Muzik, H., Turhan, A. G., Zamò, A., O'Connor, M. J., Bebb, D. G., & Lees-Miller, S. P. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0872 · Cited by 193
Pérez-Galán, P., Roué, G., Villamor, N., Campo, E., & Colomer, D. (2007) · Blood · doi:10.1182/blood-2006-07-034173 · Cited by 190
Self-citationTruncation in CCND1 mRNA alters miR-16-1 regulation in mantle cell lymphoma
Chen, R. W., Bemis, L. T., Amato, C. M., Myint, H., Tran, H., Birks, D. K., Eckhardt, S. G., & Robinson, W. A. (2008) · Blood · doi:10.1182/blood-2008-03-142182 · Cited by 189
Rao, E., Jiang, C., Ji, M., Huang, X., Iqbal, J., Lenz, G., Wright, G., Staudt, L. M., Zhao, Y., McKeithan, T. W., et al. (2012) · Leukemia · doi:10.1038/leu.2011.305 · Cited by 188
Beà, S., Salaverria, I., Armengol, L., Pinyol, M., Fernández, V., Hartmann, E. M., Jares, P., Amador, V., Hernández, L., Navarro, A., et al. (2009) · Blood · doi:10.1182/blood-2008-07-170183 · Cited by 181
Self-citationHadzidimitriou, A., Agathangelidis, A., Darzentas, N., Murray, F., Delfau-Larue, M.-H., Pedersen, L. B., Lopez, A. N., Dagklis, A., Rombout, P., Beldjord, K., et al. (2011) · Blood · doi:10.1182/blood-2011-03-343434 · Cited by 181
Self-citationCamacho, E., Hernández, L., Hernández, S., Tort, F., Bellosillo, B., Beà, S., Bosch, F., Montserrat, E., Cardesa, A., Fernández, P. L., et al. (2002) · Blood · doi:10.1182/blood.v99.1.238 · Cited by 177
Self-citationAdvances in the understanding of mantle cell lymphoma
Jares, P., & Campo, E. (2008) · British Journal of Haematology · doi:10.1111/j.1365-2141.2008.07124.x · Cited by 170
Self-citationRizzatti, E. G., Falcão, R. P., Panepucci, R. A., Proto‐Siqueira, R., Anselmo‐Lima, W. T., Okamoto, O. K., & Zago, M. A. (2005) · British Journal of Haematology · doi:10.1111/j.1365-2141.2005.05630.x · Cited by 164
Carvajal-Cuenca, A., Sua, L. F., Silva, N. M., Pittaluga, S., Royo, C., Song, J. Y., Sargent, R. L., Espinet, B., Climent, F., Jacobs, S. A., et al. (2012) · Haematologica · doi:10.3324/haematol.2011.052621 · Cited by 161
Self-citationKienle, D., Kröber, A., Katzenberger, T., Ott, G., Leupolt, E., Barth, T. F. E., Möller, P., Benner, A., Habermann, A., Müller-Hermelink, H. K., et al. (2003) · Blood · doi:10.1182/blood-2003-05-1383 · Cited by 158
The molecular signature of mantle cell lymphoma reveals multiple signals favoring cell survival.
Martı́nez, N., Camacho, F. I., Algara, P., Rodríguez, A., Dopazo, A., Ruíz-Ballesteros, E., Martín, P., Martinez-Climent, J. A., García-Conde, J., Menárguez, J., et al. (2003) · PubMed · Cited by 154
Ansell, S. M., Tang, H. J., Kurtin, P. J., et al. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70062-6 · Cited by 154
Greiner, T. C., Dasgupta, C., Ho, V. V., Weisenburger, D. D., Smith, L. M., Lynch, J. C., Vose, J. M., Fu, K., Armitage, J. O., Braziel, R. M., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510441103 · Cited by 153
Self-citationDistinct functional significance of Akt and mTOR constitutive activation in mantle cell lymphoma
Col, J. D., Zancai, P., Terrin, L., Guidoboni, M., Ponzoni, M., Pavan, A., Spina, M., Bergamin, S., Rizzo, S., Tirelli, U., et al. (2008) · Blood · doi:10.1182/blood-2007-07-103481 · Cited by 146
Younes, A., Romaguera, J. E., Fanale, M. A., McLaughlin, P. J., Hagemeister, F. B., Copeland, A. R. M., Neelapu, S. S., Kwak, L. W., Shah, J. J., Faria, S. D. C., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2012.42.5223 · Cited by 143
Hartmann, E., Campo, E., Wright, G. W., et al. (2010) · Blood · doi:10.1182/blood-2010-01-263806 · Cited by 136
Self-citationWelzel, N., Le, T., Marculescu, R., Mitterbauer, G., Chott, A., Pott, C., Kneba, M., Du, M., Kušec, R., Drach, J. W., et al. (2001) · PubMed · Cited by 129
Mottok, A., Renné, C., Seifert, M., Oppermann, E., Bechstein, W., Hansmann, M.-L., Küppers, R., & Bräuninger, A. (2009) · Blood · doi:10.1182/blood-2009-06-225839 · Cited by 124
Paoluzzi, L., Gönen, M., Bhagat, G., Furman, R. R., Gardner, J. R., Scotto, L., Gueorguiev, V. D., Heaney, M. L., Manova, K., & O’Connor, O. A. (2008) · Blood · doi:10.1182/blood-2007-12-130781 · Cited by 121
Bortezomib resistance in mantle cell lymphoma is associated with plasmacytic differentiation
Pérez‐Galán, P., Mora-Jensen, H. I., Weniger, M. A., Shaffer, A. L., Rizzatti, E. G., Chapman, C. M., Mo, C. C., Stennett, L. S., Rader, C. M., Liu, P., et al. (2010) · Blood · doi:10.1182/blood-2010-02-269514 · Cited by 119
Psyrri, A. K., Papageorgiou, S. G., Liakata, E., Scorilas, A., Rontogianni, D. P., Kontos, C. K., Argyriou, P., Pectasides, D. G., Harhalakis, N., Pappa, V., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-3215 · Cited by 117
ChIP sequencing of cyclin D1 reveals a transcriptional role in chromosomal instability in mice
Casimiro, M. C., Crosariol, M., Loro, E., Ertel, A., Yu, Z., Dampier, W., Saria, E. A., Papanikolaou, A., Stanek, T. J., Li, Z., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci60256 · Cited by 115
Constitutive activation of the Wnt canonical pathway in mantle cell lymphoma
Gélébart, P., Anand, M., Armanious, H., Peters, A., Bard, J. D., Amin, H. M., & Lai, R. L. (2008) · Blood · doi:10.1182/blood-2008-02-139212 · Cited by 114
The complex landscape of genetic alterations in mantle cell lymphoma
Royo, C., Salaverría, I., Hartmann, E., Rosenwald, A., Campo, E., & Beà, S. (2011) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2011.09.007 · Cited by 114
Self-citationKahl, B. S., Byrd, J. C., Flinn, I. W., et al. (2010) · Blood · doi:10.1182/blood.v116.21.1777.1777 · Cited by 109
Hernández, L., Beà, S., Pinyol, M., Ott, G., Katzenberger, T., Rosenwald, A., Bosch, F., López‐Guillermo, A., Delabie, J., Colomer, D., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-1526 · Cited by 106
Self-citationVogler, M., Dinsdale, D. D., Sun, X. M., Young, K. W., Butterworth, M., Nicotera, P., Dyer, M. J. S., & Cohen, G. M. (2008) · Cell Death and Differentiation · doi:10.1038/cdd.2008.25 · Cited by 103
Gupta, M., Hendrickson, A. E. W., Yun, S. S., Han, J., Schneider, P. A., Koh, B. D., Stenson, M. J., Wellik, L. E., Shing, J. C., Peterson, K. L., et al. (2011) · Blood · doi:10.1182/blood-2011-04-346601 · Cited by 102
Roué, G., Pérez‐Galán, P., López‐Guerra, M., Villamor, N., Campo, E., & Colomer, D. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.3.1923 · Cited by 90
Self-citationGesk, S., Klapper, W., Martín-Subero, J. I., Nagel, I., Harder, L., Fu, K., Bernd, H., Weisenburger, D. D., Parwaresch, R. M., & Siebert, R. (2006) · Blood · doi:10.1182/blood-2006-01-0015 · Cited by 87
Pinyol, M., Beà, S., Plà, L., Ribrag, V., Bosq, J., Rosenwald, A., Campo, E., & Jares, P. (2007) · Blood · doi:10.1182/blood-2006-11-057208 · Cited by 85
Self-citationPighi, C., Gu, T., Dalai, I., Barbi, S., Parolini, C., Bertolaso, A., Pedron, S., Parisi, A., Ren, J., Cecconi, D., et al. (2011) · Cellular Oncology · doi:10.1007/s13402-011-0019-7 · Cited by 83
Navarro, A., Beà, S., Fernández, V., Prieto, M., Salaverría, I., Jares, P., Hartmann, E., Mozos, A., López‐Guillermo, A., Villamor, N., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-1095 · Cited by 82
Self-citationMolecular Pathways: Targeting Proteasomal Protein Degradation in Cancer
Molineaux, S. M. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-0853 · Cited by 79
Baran‐Marszak, F., Boukhiar, M.-A., Harel, S., Laguillier, C., Roger, C., Gressin, R., Martin, A., Fagard, R., Varin‐Blank, N., Cymbalista, F., et al. (2010) · Haematologica · doi:10.3324/haematol.2009.019745 · Cited by 74
Georgakis, G. V., Li, Y., & Younes, A. (2006) · British Journal of Haematology · doi:10.1111/j.1365-2141.2006.06247.x · Cited by 73
Mantle cell lymphoma proliferates upon IL-10 in the CD40 system
Visser, H., Tewis, M., Willemze, R., & Kluin‐Nelemans, H. C. (2000) · Leukemia · doi:10.1038/sj.leu.2401829 · Cited by 70
Burger, J. A., & Ford, R. J. (2011) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2011.09.006 · Cited by 65
Kolar, G. R., Mehta, D., Pelayo, R., & Capra, J. D. (2006) · Blood · doi:10.1182/blood-2006-07-037150 · Cited by 64
Slotta‐Huspenina, J., Koch, I., de Leval, L., Keller, G., Klier, M., Bink, K., Kremer, M., Raffeld, M. A., Fend, F., & Quintanilla‐Martínez, L. (2012) · Haematologica · doi:10.3324/haematol.2011.055715 · Cited by 61
Beltrán, E., Fresquet, V., Martínez‐Useros, J., Richter, J. Á., Sagardoy, A., Sesma, I., Almada, L. L., Montes‐Moreno, S., Siebert, R., Gesk, S., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1018941108 · Cited by 61
Expression of STAT3 and its phosphorylated forms in mantle cell lymphoma cell lines and tumours
Lai, R. L., Rassidakis, G. Z., Medeiros, L. J., Leventaki, V., Keating, M., & McDonnell, T. J. (2002) · The Journal of Pathology · doi:10.1002/path.1253 · Cited by 60
New molecular targets in mantle cell lymphoma
Parekh, S. S., Weniger, M. A., & Wiestner, A. U. (2011) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2011.09.008 · Cited by 51
Interleukin 22 Signaling Promotes Cell Growth in Mantle Cell Lymphoma
Gélébart, P., Zak, Z., Bard, J. D., Anand, M., & Lai, R. L. (2011) · Translational Oncology · doi:10.1593/tlo.10172 · Cited by 47
Epigenetic Activation of SOX11 in Lymphoid Neoplasms by Histone Modifications
Vegliante, M. C., Royo, C., Palomero, J., Salaverría, I., Bálint, B., Martín‐Guerrero, I., Agirre, X., Lujambio, A., Richter, J., Xargay‐Torrent, S., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021382 · Cited by 42
Self-citationProteasome Inhibition and Combination Therapy for Non-Hodgkin's Lymphoma: From Bench to Bedside
Mato, A. R., Feldman, T. A., & Goy, A. H. (2012) · The Oncologist · doi:10.1634/theoncologist.2011-0341 · Cited by 36
Bártek, J., & Lukas, J. (2011) · Nature · doi:10.1038/474171a · Cited by 34
Temsirolimus for the treatment of mantle cell lymphoma
Heß, G. (2009) · Expert Review of Hematology · doi:10.1586/ehm.09.57 · Cited by 18
Golla, R. M., Li, M., Shen, Y., Ji, M. H., Yan, Y., Fu, K., Greiner, T. C., McKeithan, T. W., & Chan, W. C. (2011) · Hematological Oncology · doi:10.1002/hon.1020 · Cited by 17
Should There Be a Standard Therapy for Mantle Cell Lymphoma?
Smith, M. R. (2011) · Future Oncology · doi:10.2217/fon.10.189 · Cited by 14
Cited by
The 2016 revision of the World Health Organization classification of lymphoid neoplasms
Swerdlow, S. H., Campo, E., Pileri, S. A., Harris, N. L., Stein, H., Siebert, R., Advani, R., Ghielmini, M., Salles, G. A., Zelenetz, A. D., et al. (2016) · Blood · doi:10.1182/blood-2016-01-643569 · Cited by 7,831
“Two types of clinically indolent variants are now recognized and reflect, in part, that MCL develops along 2 very different pathways (Figure 2).(31) Classical MCL is usually composed of IGHV-unmutated or minimally mutated B cells that usually express SOX11 and typically involves lymph nodes and other extranodal sites.”
BackgroundSelf-citationArmitage, J. O., Gascoyne, R. D., Lunning, M. A., & Cavalli, F. (2017) · The Lancet · doi:10.1016/s0140-6736(16)32407-2 · Cited by 1,176
Targeting Bruton's tyrosine kinase in B cell malignancies
Hendriks, R. W., Yuvaraj, S., & Kil, L. P. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3702 · Cited by 552
The tumour microenvironment in B cell lymphomas
Scott, D. W., & Gascoyne, R. D. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3774 · Cited by 552
Landscape of somatic mutations and clonal evolution in mantle cell lymphoma
Beà, S., Valdés-Mas, R., Navarro, A., Salaverria, I., Martín-Garcia, D., Jares, P., Giné, E., Pinyol, M., Royo, C., Nadeu, F., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1314608110 · Cited by 513
Self-citation
Metadata
- Authors
- Jares, P., Colomer, D., & Campo, E.
- Venue
- Journal of Clinical Investigation
- Published
- 2012-10-01
- Volume
- 122
- Issue
- 10
- Pages
- 3416-3423
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2040669551
- Cited by
- 382
- References
- 92
- FWCI
- 19.33
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.